Atlas Trials

Concurrent Immunotherapy With Postoperative Radiotherapy in Intermediate/High Risk HNSCC Patients Unfit for Cisplatin: The IMPORT Study (IMPORT)

Clinical trial NCT04523883 · UNKNOWN

Trial details

NCT number
NCT04523883
Sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Squamous Cell Carcinoma
Start date
2020-08-10
Primary completion
2022-08-09
Enrollment
316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.